MedTrace Logo

Adapted Solution Focused Therapy for People With Aphasia (SOFIA Trial)

NCT03245060 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-02-10

No results posted yet for this study

Summary

Around one third of stroke survivors will have aphasia, which means they will have difficulty talking, understanding, reading or writing. The main aims of this study are to assess: \[1\] the acceptability of an existing psychosocial intervention, solution focused brief therapy, to people with varying presentations of aphasia; and \[2\] the feasibility of conducting a future definitive trial investigating clinical and cost effectiveness.

Conditions

Interventions

BEHAVIORAL

Adapted Solution Focused Brief Therapy

Solution Focused Brief Therapy is an approach to building positive change in a person's life. It builds up a picture of a client's preferred future (or how a person would like their life to be); encourages a person to notice positive signs of change; and explores personal resources, skills and resilience. In the present project, the therapy has been adapted so that it works well with people who have a language disability.

Sponsors & Collaborators

  • City, University of London

    lead OTHER

Principal Investigators

  • Sarah Northcott, PhD · City, University of London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-17
Primary Completion
2019-08-14
Completion
2019-08-14

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245060 on ClinicalTrials.gov